Drugs / Refresh
Trials 0
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT00796926 Comparator | Jul 2009 → Nov 2010 | blepharitis, xerophthalmia | Louis Tong | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03666884 Comparator | Oct 2015 → Mar 2016 | dry eye syndrome | Seref istek | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01384851 Comparator | Jul → Nov 2011 | dry eye syndrome | Glasgow Caledonian University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Refresh | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00796926 ↗ |
| Known as | Refresh Dry Eye Therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01384851 ↗ |
| Route | Topical | “Used four times a day topically to each eye” NCT00796926 ↗ |